COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.
Eclinicalmedicine
Szubert, Alex J AJ; Pollock, Katrina M KM; Cheeseman, Hannah M HM; Alagaratnam, Jasmini J; Bern, Henry H; Bird, Olivia O; Boffito, Marta M; Byrne, Ruth R; Cole, Tom T; Cosgrove, Catherine A CA; Faust, Saul N SN; Fidler, Sarah S; Galiza, Eva E; Hassanin, Hana H; Kalyan, Mohini M; Libri, Vincenzo V; McFarlane, Leon R LR; Milinkovic, Ana A; O'Hara, Jessica J; Owen, David R DR; Owens, Daniel D; Pacurar, Mihaela M; Rampling, Tommy T; Skene, Simon S; Winston, Alan A; Woolley, James J; Yim, Yee Ting N YTN; Dunn, David T DT; McCormack, Sheena S; Shattock, Robin J RJ; ,
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial.
Eclinicalmedicine
Pollock, Katrina M KM; Cheeseman, Hannah M HM; Szubert, Alexander J AJ; Libri, Vincenzo V; Boffito, Marta M; Owen, David D; Bern, Henry H; O'Hara, Jessica J; McFarlane, Leon R LR; Lemm, Nana-Marie NM; McKay, Paul F PF; Rampling, Tommy T; Yim, Yee Ting N YTN; Milinkovic, Ana A; Kingsley, Cherry C; Cole, Tom T; Fagerbrink, Susanne S; Aban, Marites M; Tanaka, Maniola M; Mehdipour, Savviz S; Robbins, Alexander A; Budd, William W; Faust, Saul N SN; Hassanin, Hana H; Cosgrove, Catherine A CA; Winston, Alan A; Fidler, Sarah S; Dunn, David T DT; McCormack, Sheena S; Shattock, Robin J RJ; ,